Yanjie Zhang, MD
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Perioperative Finotonlimab Plus Chemotherapy in Untreated Stage II HNSCC (NCT07751276) | Yanjie Zhang, MD | 2026-08-01 |
| Anti-PD-1 Therapy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma (NCT07751289) | Yanjie Zhang, MD | 2026-08-01 |
| Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans (NCT07646080) | Yanjie Zhang, MD | 2026-06-15 |
Track Yanjie Zhang, MD automatically
Every clearance here is in the API, with alerts when new ones post.